Literature DB >> 11917540

Inflammatory mediators in CF patients.

Jay B Hilliard1, Michael W Konstan, Pamela B Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11917540     DOI： 10.1385/1-59259-187-6:409

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  9 in total

1.  Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding.

Authors:  Pamela L Zeitlin; Marie Diener-West; Karen A Callahan; Seakwoo Lee; C Conover Talbot; Bette Pollard; Michael P Boyle; Noah Lechtzin
Journal:  Ann Am Thorac Soc       Date:  2017-02

2.  Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction.

Authors:  Patricia L Jackson; Xin Xu; Landon Wilson; Nathaniel M Weathington; John Paul Clancy; James Edwin Blalock; Amit Gaggar
Journal:  Mol Med       Date:  2010-01-22       Impact factor: 6.354

3.  Selective metabolism of hypothiocyanous acid by mammalian thioredoxin reductase promotes lung innate immunity and antioxidant defense.

Authors:  Joshua D Chandler; David P Nichols; Jerry A Nick; Robert J Hondal; Brian J Day
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

4.  Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling.

Authors:  Emanuela M Bruscia; Ping-Xia Zhang; Christina Barone; Bob J Scholte; Robert Homer; Diane S Krause; Marie E Egan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-05       Impact factor: 5.464

5.  Antiinflammatory and Antimicrobial Effects of Thiocyanate in a Cystic Fibrosis Mouse Model.

Authors:  Joshua D Chandler; Elysia Min; Jie Huang; Cameron S McElroy; Nina Dickerhof; Tessa Mocatta; Ashley A Fletcher; Christopher M Evans; Liping Liang; Manisha Patel; Anthony J Kettle; David P Nichols; Brian J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2015-08       Impact factor: 6.914

6.  In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients.

Authors:  Andreas Hector; Matthias Kappler; Matthias Griese
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

7.  Reduced caveolin-1 promotes hyperinflammation due to abnormal heme oxygenase-1 localization in lipopolysaccharide-challenged macrophages with dysfunctional cystic fibrosis transmembrane conductance regulator.

Authors:  Ping-Xia Zhang; Thomas S Murray; Valeria R Villella; Eleonora Ferrari; Speranza Esposito; Anthony D'Souza; Valeria Raia; Luigi Maiuri; Diane S Krause; Marie E Egan; Emanuela M Bruscia
Journal:  J Immunol       Date:  2013-04-19       Impact factor: 5.422

8.  Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- mice.

Authors:  Emanuela M Bruscia; Ping-Xia Zhang; Elisa Ferreira; Christina Caputo; John W Emerson; David Tuck; Diane S Krause; Marie E Egan
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-05       Impact factor: 6.914

9.  Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis.

Authors:  Theodore G Liou; Frederick R Adler; Natalia Argel; Fadi Asfour; Perry S Brown; Barbara A Chatfield; Cori L Daines; Dixie Durham; Jessica A Francis; Barbara Glover; Theresa Heynekamp; John R Hoidal; Judy L Jensen; Ruth Keogh; Carol M Kopecky; Noah Lechtzin; Yanping Li; Jerimiah Lysinger; Osmara Molina; Craig Nakamura; Kristyn A Packer; Katie R Poch; Alexandra L Quittner; Peggy Radford; Abby J Redway; Scott D Sagel; Shawna Sprandel; Jennifer L Taylor-Cousar; Jane B Vroom; Ryan Yoshikawa; John P Clancy; J Stuart Elborn; Kenneth N Olivier; David R Cox
Journal:  BMC Med Res Methodol       Date:  2019-04-26       Impact factor: 4.615
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.